Dog · Canis lupus familiaris · typical adult weight 2.00–80.00 kg
Piroxicam Compounded Oral is dosed at 0.3 mg/kg PO q24-48h in dogs, per Knapp DW, Richardson RC, Chan TC, et al. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med. 1994;8(4):273-278. doi:10.1111/j.1939-1676.1994.tb03232.x — Verified against Plumb's Veterinary Drug Handbook, 10th Ed, p.1062 (2026-08-01).. Piroxicam Compounded Oral is used in dogs for Transitional cell carcinoma (TCC/urothelial carcinoma), Squamous cell carcinoma (palliative). Routes documented in dogs: PO. A typical adult dog weighs 2.00–80.00 kg. ExoticRx lists 2 cited dose rules for Piroxicam Compounded Oral in dogs, drawn from published veterinary references. Verify against current literature before clinical use.
US trade names: Feldene Vet Compounded
| Route | Dose | Frequency | Duration | Indication | Evidence | Source |
|---|---|---|---|---|---|---|
| PO | 0.3 mg/kg | q24-48h | Long-term palliative; GI protectants recommended concurrently | Transitional cell carcinoma (TCC/urothelial carcinoma) | Strong | Knapp DW, Richardson RC, Chan TC, et al. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med. 1994;8(4):273-278. doi:10.1111/j.1939-1676.1994.tb03232.x — Verified against Plumb's Veterinary Drug Handbook, 10th Ed, p.1062 (2026-08-01). |
| PO | 0.3 mg/kg | q24-48h | Long-term palliative; monitor renal values and for GI bleeding | Squamous cell carcinoma (palliative) | Moderate | Knapp DW, Richardson RC, Chan TC, et al. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med. 1994;8(4):273-278. doi:10.1111/j.1939-1676.1994.tb03232.x — Verified against Plumb's Veterinary Drug Handbook, 10th Ed, p.1062 (2026-08-01). |
Need the exact dose for your patient?
These ranges are per kg. Enter your dog's weight to get the precise dose and draw-up volume — unit and concentration math done for you.
Non-selective COX inhibitor with anti-proliferative and anti-angiogenic properties used as adjunctive treatment for transitional cell carcinoma and other tumors.
GI ulceration risk significant — use with misoprostol or omeprazole. Monitor BUN/creatinine. Every-other-day dosing common to reduce toxicity. Not for cats.
Species-specific contraindications and adverse-reaction reports for dogs may differ from canine / feline reference data — consult the primary citations listed with each rule.
Piroxicam Compounded Oral dose ranges in dogs, with cited source references: PO 0.3 mg/kg q24-48h; PO 0.3 mg/kg q24-48h. Reference ranges from cited sources — verify against current literature before clinical use.
Documented routes for Piroxicam Compounded Oral in dogs: PO.
Cited course lengths for Piroxicam Compounded Oral in dogs include: Long-term palliative; GI protectants recommended concurrently; Long-term palliative; monitor renal values and for GI bleeding. Duration depends on the indication — match it to the specific dose rule in the table above.
Piroxicam Compounded Oral is indicated in dogs for: Transitional cell carcinoma (TCC/urothelial carcinoma), Squamous cell carcinoma (palliative).
These are general warnings for Piroxicam Compounded Oral across species; consult the dog dosing table above for species-specific guidance. GI ulceration risk significant — use with misoprostol or omeprazole. Monitor BUN/creatinine. Every-other-day dosing common to reduce toxicity. Not for cats.
Why a species-specific page? Piroxicam Compounded Oral pharmacokinetics differ across species: dose ranges, intervals, and route preferences are not interchangeable. Cross-extrapolation from canine doses is unsafe in dogs — the rules above are the citations specific to this species, not generic recommendations.
Sourced from published veterinary references; awaiting credentialed clinical reviewer. See our editorial process. Reference only — not veterinary advice.